Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Fechter Karoline |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Originalarbeit (Zeitschrift)
** Vejzovic, D; Kubin, A; Fechter, K; Karner, C; Hartmann, J; Ackerbauer, T; Radović, B; Ritter, G; Üçal, M; Ropele, S; Ali, KM; Mischkulnig, M; Leoni, M; Liegl-Atzwanger, B; Wightman, L; Rinner, B
Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing.
Biomed Pharmacother. 2025; 186:118041
Doi: 10.1016/j.biopha.2025.118041
PubMed
FullText
FullText_MUG
2022
Übersichtsarbeit
** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162.
Doi: 10.4251/wjgo.v14.i1.153
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA.
Doi: 10.1182/blood-2022-163034
[Poster]
Web of Science
FullText
FullText_MUG
2021
Übersichtsarbeit
** Pansy, K; Uhl, B; Krstic, J; Szmyra, M; Fechter, K; Santiso, A; Thüminger, L; Greinix, H; Kargl, J; Prochazka, K; Feichtinger, J; Deutsch, AJ
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Int J Mol Sci. 2021; 22(24):
Doi: 10.3390/ijms222413311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
2018
Originalarbeit (Zeitschrift)
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528
Doi: 10.1038/s41598-018-32972-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79.
Doi: 10.1038/s41408-018-0112-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A
Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien.
[Poster]
Web of Science
** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
** Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A
Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
2017
Originalarbeit (Zeitschrift)
** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386
Doi: 10.1158/0008-5472.CAN-16-2320
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fechter, K; Dorronsoro, A; Jakobsson, E; Ferrin, I; Lang, V; Sepulveda, P; Pennington, DJ; Trigueros, C
IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells.
PLoS One. 2017; 12(1): e0169362-e0169362.
Doi: 10.1371/journal.pone.0169362
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Deutsch, A; Pursche, B; Ehall, B; Zoidl, M; Fechter, K; Steinbauer, E; Sedej, M; Greinix, H; Prochazka, K; Wrodnigg, T; Beham-Schmid, C; Neumeister, P;
CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO.
HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
** Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas
VIRCHOWS ARCH. 2017; 471: S43-S43.
[Poster]
Web of Science
2016
Abstract (Zeitschrift)
** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P;
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
Doi: 10.1182/blood.V128.22.2728.2728
Web of Science
FullText
FullText_MUG
2014
Originalarbeit (Zeitschrift)
** Dorronsoro, A; Ferrin, I; Salcedo, JM; Jakobsson, E; Fernández-Rueda, J; Lang, V; Sepulveda, P; Fechter, K; Pennington, D; Trigueros, C
Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.
Eur J Immunol. 2014; 44(2):480-488
Doi: 10.1002/eji.201343668
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Dorronsoro, A; Lang, V; Jakobsson, E; Ferrin, I; Salcedo, JM; Fernández-Rueda, J; Fechter, K; Rodriguez, MS; Trigueros, C
Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis.
Cell Death Dis. 2013; 4(1):e972-e972
Doi: 10.1038/cddis.2013.494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Dorronsoro, A; Fernández-Rueda, J; Fechter, K; Ferrin, I; Salcedo, JM; Jakobsson, E; Trigueros, C
Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications.
Bone Marrow Res. 2013; 2013(5):203643-203643
Doi: 10.1155/2013/203643
[OPEN ACCESS]
PubMed
FullText
FullText_MUG